Unicycive Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| GREAT POINT PARTNERS LLC | 11/13/2024 | 8.56 M | $3.49 B | 100.00% | 9.62% |
| OCTAGON CAPITAL ADVISORS LP | 11/14/2024 | 8.56 M | $3.49 M | 100.00% | 9.62% |
| LOGOS GLOBAL MANAGEMENT LP | 11/14/2024 | 5.08 M | $2.07 M | 46.37% | 5.71% |
| WALLEYE CAPITAL LLC | 11/14/2024 | 5.00 M | $2.04 M | 100.00% | 5.62% |
| VIVO CAPITAL, LLC | 11/13/2024 | 4.47 M | $1.82 M | 28.82% | 5.03% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 11/14/2024 | 4.00 M | $1.63 M | 100.00% | 4.50% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 11/14/2024 | 2.82 M | $1.15 M | 0.00% | 3.17% |
| ALYESKA INVESTMENT GROUP, L.P. | 11/14/2024 | 2.25 M | $917,775 | 100.00% | 2.53% |
| ACUTA CAPITAL PARTNERS, LLC | 11/14/2024 | 1.98 M | $807,315 | 100.00% | 2.23% |
| ALTIUM CAPITAL MANAGEMENT LP | 11/14/2024 | 1.47 M | $600,837 | 100.00% | 1.66% |
| VANGUARD GROUP INC | 11/13/2024 | 1.14 M | $464,394 | 0.00% | 1.28% |
| LPL FINANCIAL LLC | 11/08/2024 | 466,005 | $190,083 | 448.24% | 0.52% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 402,398 | $164,138 | 40.83% | 0.45% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 93,424 | $38,108 | 0.08% | 0.11% |
| BLEAKLEY FINANCIAL GROUP, LLC | 10/16/2024 | 80,000 | $32,632 | 100.00% | 0.09% |
| VIRTU FINANCIAL LLC | 11/20/2024 | 73,975 | $30,000 | 566.80% | 0.08% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 71,821 | $29,296 | 100.00% | 0.08% |
| XTX TOPCO LTD | 11/14/2024 | 70,784 | $28,873 | 100.00% | 0.08% |
| STATE STREET CORP | 11/14/2024 | 43,936 | $17,921 | 0.00% | 0.05% |
| JANE STREET GROUP, LLC | 11/15/2024 | 41,249 | $16,826 | 100.00% | 0.05% |
| TWO SIGMA SECURITIES, LLC | 11/14/2024 | 23,266 | $9,490 | 100.00% | 0.03% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2024 | 22,782 | $9,295 | 23.25% | 0.03% |
| CAPTRUST FINANCIAL ADVISORS | 11/14/2024 | 18,800 | $7,669 | 0.00% | 0.02% |
| TANDEM CAPITAL MANAGEMENT CORP /ADV | 10/25/2024 | 15,500 | $6,322 | 0.00% | 0.02% |
| CREATIVE PLANNING | 10/11/2024 | 10,231 | $4,173 | 100.00% | 0.01% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 332 | $135 | 48.88% | 0.00% |
| JPMORGAN CHASE & CO | 11/08/2024 | 207 | $84 | 195.71% | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 0 | $0 | -100.00% | 0.00% |
| BVF INC/IL | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| RA CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| ROSALIND ADVISORS, INC. | 10/30/2024 | 0 | $0 | -100.00% | 0.00% |
| MONASHEE INVESTMENT MANAGEMENT LLC | 11/12/2024 | 0 | $0 | -100.00% | 0.00% |
| REDWOOD WEALTH MANAGEMENT GROUP, LLC | 11/13/2024 | 0 | $0 | -100.00% | 0.00% |
| SCIENTECH RESEARCH LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
Unicycive Therapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of UNCY shares?
During the previous two years, 37 institutional investors and hedge funds held shares of Unicycive Therapeutics, Inc.. The most heavily invested institutionals were:
Octagon Capital Advisors LP: 8.56 M
GREAT POINT PARTNERS LLC: 8.56 M
Logos Global Management LP: 5.08 M
Walleye Capital LLC: 5 M
Vivo Capital, LLC: 4.47 M
SILVERARC CAPITAL MANAGEMENT, LLC: 4 M
-
What percentage of Unicycive Therapeutics, Inc. stock is owned by institutional investors?
52.60% of Unicycive Therapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at UNCY ?
Institutional investors have bought a total of 46.83 M shares in the last 24 months. This purchase volume represents approximately $33.25 M in transactions.